J., AND BAAN, R. A. (1997) . Fundam. Appl. Toxicol. 35, [131] [132] [133] [134] [135] [136] [137] Hydrazine belongs to a group of compounds for which there is evidence that the in vivo genotoxic effects become manifest only upon exposure to toxic dose levels. The present study was performed to investigate whether this phenomenon is also reflected in the pattern of DNA methylation. The induction of N7-and O 6 -methylguanine (MeGua) was studied in liver DNA of rats, 16 hr after treatment with various doses of hydrazine. After DNA isolation, the presence of N7-MeGua in DNA was assessed with an immunochemical method and with a physicochemical technique (HPLC with electrochemical detection). Application of these two methods resulted in almost identical patterns of dose-dependent induction of guanine N7-methylation in rats dosed orally with 0.1 to 10 mg hydrazine per kilogram of body weight, increasing from 1.1-1.3 to 39-45 N7-MeGua per 10 6 nucleotides. At lower dosages a constant adduct level was observed, equivalent to that in untreated rats (background level). The O 6 -MeGua level was analyzed by a combination of HPLC separation and competitive radioimmunoassay. A background level was observed for untreated rats and no increase was visible up to the 0.2 mg/kg dose group. After hydrazine doses from 0.2 to 10 mg/kg, O 6 -MeGua increased from 0.29 to 134 per 10' nucleotides. These data show that even at dosages below the maximum tolerated dose (0.6 mg/kg/day), for which carcinogenic effects have not been described, DNA adducts are formed. A comparison is made of the data obtained in this study with models that describe the mechanism of hydrazine-induced DNA methylation. © lwsocien ofTo«koiog>.
In carcinogenicity bioassays, the maximum tolerated dose is often used to ensure that no chemical goes unnoticed as a carcinogen because too low a dose has been applied or because too few animals were used in the study (Haseman. 1985) . However, in many instances the confounding toxicological factors that may be introduced by the use of maximum tolerated doses are often neglected. Such confounding effects render it less likely that the carcinogenicity of a particular compound established in rodents may apply to humans exposed to much lower levels of the agent (Ames and Gold, 1990) . In carcinogenic risk assessment, the group of compounds that exert their apparent mutagenic and carcinogenic activity via an indirect mechanism deserves special attention. One example of such a mechanism is the toxicityrelated aberrant methylation that has been proposed as the mode of action of chemicals like hydrazine and carbon tetrachloride.
Single oral dosages of hydrazine give rise to formation of N7-and O 6 -methylguanine (MeGua) 1 in liver DNA in rats, mice, hamsters, and guinea pigs. A dose-dependent formation of these adducts has been demonstrated in rats and hamsters for toxic doses of hydrazine, viz. above 30 mg per kilogram of body weight (Becker et ai, 1981; Bosan and Shank, 1983; Bosan et ai, 1986) , whereas the LD50 value for the rat is 60 to 80 mg/kg (O'Brien et ai, 1964) .
Hydrazine induces mutations and/or chromosome aberrations in a wide variety of organisms. Metabolic activation was found to be necessary in most cases, but in some test systems the compound appeared active without activation (see Ashby, 1981 , for an evaluation of these data). In rodents, hydrazine produces tumors at various sites after chronic exposure to high doses, viz. more than the maximum tolerated dose, via inhalation or the drinking water (Vernot et ai., 1985 . Steinhoff et ai, 1988 , 1990 . No conclusive evidence exists for hydrazine-induced cancer in man (Toth, 1994) .
Currently, hydrazine is primarily used as a raw material in the manufacturing of agricultural chemicals, blowing agents, polymerization catalysts, pharmaceutical products, as a corrosion inhibitor in boiler water, and as a propellant fuel. Hydrazine is not known to occur in nature, except perhaps in the tobacco plant (Liu et al, 1974) . As mentioned above, hydrazine belongs to a group of compounds for which there is evidence that the in vivo genotoxic effects become manifest only upon exposure to toxic dose levels. The present study was performed to investigate whether this phenomenon is reflected also in the pattern of DNA methylation after in vivo exposure of rats to various dosages of hydrazine. In this paper information is provided on the formation of N7-and O 6 -methylguanine in liver DNA of rats after oral dosages of hydrazine that are below the toxic level.
METHODS

Animal experiments.
Wistar rats were fasted overnight and dosed by gavage with various amounts of hydrazine in O.I M HC1 (0.01-10 mg hydrazine/kg body wt). Control rats received vehicle only. Each dose group comprised three to six rats. Sixteen hours later, the animals were sacrificed and the livers were removed, frozen, and pulverized.
Isolation, purification, and characterization of DNA. During the extraction and purification of the DNA from the livers of hydrazine-treated rats, care was taken to keep the release of N7-linked alkylguanine adducts as low as possible. Therefore, the manipulations described below were carried out at 4°C, except where indicated otherwise. Control experiments indicated that the loss of N7-MeGua as a result of the procedure is less than 10%.
The protocol described below concerns the processing of 1 g of liver tissue. The pulverized liver was homogenized in 9 ml 0 25 M sucrose, 0.1 M EDTA, pH 7.4, by use of a Potter-Elvehjem homogenizer. Nuclei were isolated by centrifugation for 1 min at 7000 rpm (r av = 70 mm). The supernatant was set aside for isolation and analysis of cytoplasmic RNA (see below). The nuclear pellet was washed with the same buffer and resuspended in 9 ml of 0.25 M sucrose, 25 mM EDTA, 1% Triton, pH 7.4, and incubated for 40 min at 4°C. The chromatin was isolated by centrifugation for 10 min at 3000 rpm (r av = 70 mm) and washed three times with 10 mM Tris-HCl, pH 7.4. The pellet was then resuspended in 2.5 ml TENbuffer (20 mM Tris-HCl, pH 7.4, 1 mM EDTA, 100 mM NaCl). The protein components of the chromatin were degraded by dropwise addition of 2.5 ml TEN-buffer, containing 1% (w/v) SDS and 100 Tg Proteinase K (Merck, Darmstadt, Germany)/ml, and incubation for 16 hr at 25°C. Protein was then removed by three successive extractions with 5 ml each of phenol (saturated with Tris-HCl, pH 8.0), phenol/chloroform/isoamyl alcohol (25:24:1 v/v), and chloroform/isoamyl alcohol (24:1 v/v), respectively. The nucleic acids in the aqueous phase were precipitated by addition of sodium acetate, pH 5.6 (0.3 M), and 2.5 vol of absolute ethanol (-20°C). The precipitate was washed twice with 70% ethanol, dried in vacua, and finally dissolved in 5 ml of 10 mM Tris-HCl, pH 7.4, 1 mM EDTA.
RNA was degraded by addition of RNAse A (75 /xg/ml: Sigma. St. Louis, MO) and RNAse /tl (75 U/ml; Boehringer, Mannheim. Germany) and incubation at 37°C for 1 hr. After this incubation, 500 /J.\ of 10X TENbuffer and 500 /xl of 10% SDS were added. The same series of extractions as described above was then repeated to remove enzymes and degraded RNA. The purified DNA was precipitated, washed with 70% ethanol, dried, and dissolved in 1 ml of 10 mM potassium phosphate, pH 7.0. The DNA concentration was determined from the absorbance at 260 nm, assuming that for 1 mg/ml the A 26 o = 20. The overall purity of the DNA was verified by the determination of the /^w/Ajso and the Ajao/A^m ratios of the DNA solution
The remaining contamination with RNA in the purified DNA samples was estimated by the determination of 3'-riboguanosine monophosphate (3'-GMP) in an enzymic DNA digest. Ten micrograms of the DNA was digested to deoxyribonucleoside 3'-monophosphates (dNp) with 0.6 U of micrococcal nuclease (Sigma) and 0.01 U of spleen phosphodiesterase (Sigma) in 12 /zl of 20 mM sodium succinate, pH 6.0, 10 mM CaCl 2 at 37°C for 3 hr. The amount of contaminating 3'-GMP was determined by anionexchange chromatography on a Mono Q column HR 5/5 (FPLC system, Pharmacia, Sweden). The column was eluted at a flow rate of 1 ml/min with buffer A (12.5 mM Tris, pH 8.85) and buffer B (12.5 mM Tris, 1 M NaCl, pH 8.85) as follows: 3 min with 6.5% B, in 6 min from 6.5 to 15% B, 3.5 min with 15% B, and finally during 2 5 min with 100% B (this last elution step at 2 ml/min). Under these conditions, 3'-GMP (Rt = 11.8 min) can be separated and distinguished from 3'-dGMP (Rt = 9.7 min) and other nucleotides.
Routinely, 1-1.5 mg DNA was isolated per gram of liver. UV spectra of the samples confirmed the purity of the DNA (A 2 w/Aino = 1.9-2.0 and A2W/A230 = 2.2-2.3). RNA contamination in the DNA samples was estimated to be less than 0.1 %.
Isolation of RNA. Rat liver RNA was isolated from the supernatant remaining after isolation of liver cell nuclei by centrifugation (see above)
The supernatant was extracted with phenol, phenol/chloroform/isoamyl alcohol, and chloroform/isoamyl alcohol as described for the isolation of DNA. The RNA was precipitated with sodium acetate (0.3 M) and 2.5 vol of absolute ethanol (-20°C), washed with 70% ethanol. and dried in vacuo Just before further analysis, the RNA was dissolved in the appropriate buffer. FPLC analysis of the isolated rat liver RNA showed no detectable contamination with DNA. However, according to UV spectra the RNA was not entirely free of other, unidentified components.
Immunochemical analysis of N7-MeGua. DNA dissolved in 10 mM KH2PO4-KOH, pH 7.0 (1 -1.5 mg/ml), was sonicated at maximal amplitude for 10 sec at 0°C (MSE sonicator). Per 1 ml DNA, 23 /zl of 3 M NaOH was then added, followed by incubation for 30 min at 37°C. This leads to opening of the imidazole ring of N7-MeGua. The solution was neutralized by addition of 30 /il 1 M K 2 HPO 4 and 75-85 /il 1 M HC1 until pH AF 7.4. Just prior to use in the competitive enzyme-linked immunosorbent assay (ELISA), the DNA was heat-denatured (10 min 100°C followed by rapid cooling at 0°C) and treated with SDS (0.0033%; 3 min at 56°C).
The protocol of the competitive ELISA, described in detail by Van Delft et al. (1991) , was briefly as follows. Various dilutions, in duplicate, of the inhibiting antigen, e.g., unmodified and methylated DNA, were mixed with a fixed amount of the monoclonal antibody N7E-026 [specific for imidazole ring-open N7-MeGua and N7-ethylguanine (N7-EtGua) in DNA; Van Delft et al., 1991] . After incubation for 45 min at 37°C, the mixture was transferred to microtiter plates coated with alkali-treated and heat-denaturated /V-methyl-/V-nitrosourea (MNU)-modified calf thymus DNA (0.062 /xg per well; one N7-MeGua per 710 nucleotides) and incubated for 1 hr at 37°C. Unbound antibodies were removed in several wash steps, after which bound antibodies were marked with an alkaline phosphatase-labeled goat antimouse-IgG (KPL, Gaithersburg, MD) during an incubation for 1 hr at 37°C. After a final wash, 20 /ZM 4-methylumbelliferyl phosphate was added and incubated for 2 hr at 37°C. The resulting fluorescence was recorded with a Fluoroskan (Eflab, Finland), inhibition curves obtained with unknown DNA samples were compared with that of a calibration standard (calf thymus DNA treated with 40 fiM MNU containing 44 N7-MeGua per 10 6 nucleotides). At the 50% inhibition point, the amount of N7-MeGua per well for each curve is identical and can be read from the calibration curve. From this, the N7-methylation levels of the unknown DNA samples were calculated.
Immunochemical analysis of 0 6 -MeGua. Enzymatic hydrolysis of DNA to mono-2'-deoxynucleosides was performed as previously described (Adamkiewicz et al., 1986) , using DNase 1 (200 /ig/ml; Boehringer-Mann-heim), alkaline phosphatase (180 U/ml; Boehringer-Mannheim). and phosphodiesterase (100 /ig/ml: Boehringer-Mannheim). DNA of four rats was pooled for the hydrazine doses of 0.2 mg/kg. whereas DNA of three animals was pooled for the dosages 0 and 0.7 mg/kg. For the higher dosages, DNA of single animals was analyzed, with two animals per dose. DNA hydrolysates (ranging from 0.3 to 31 mg) were separated by HPLC (Waters. Eschborn. Germany) using a reversed-phase Nova-Pak phenyl cartridge (Waters). The solvent system consisted of a mobile phase A of 0.1 M ammonium formiate. pH 5.0. and a mobile phase B of 100% methanol. Elution was performed with increasing concentrations of B in A at a flow rate of 1 ml/min at 37°C. Caffeine was added as an elution standard.
3 Hlabeled O 6 -MedGuo was used to calibrate the system.
The competitive radioimmunoassay (RIA) was carried out as described by Miiller and Rajewsky (1978) . using the highly specific monoclonal antibody EM-21 (Eberle, 1989) for the determination of O 6 -MedGuo. In a total volume of 100 fA of Tris-buffered saline, each sample contained about 2000 dpm of 3 H-labeled tracer, an antibody dilution to give 50% binding of tracer in the absence of inhibitor, plus various amounts of O 6 -MedGuo. After incubation for 4 hr at 4°C, 100 fi\ of saturated ammonium sulfate (pH 7) was added. After 10 min the samples were centrifuged for 4 min at lO.OOOg. The 3 H-activity in 150 /x\ of supernatant was measured by liquid scintillation spectrometry. The degree of inhibition of tracer-antibody binding (ITAB) was calculated as described by Miiller (1980) . Amounts of O 6 -MedGuo in the samples were determined by comparing the respective ITAB values with standard curves, obtained with known amounts of O 6 -MedGuo.
Electrochemical analysis. The protocol of the electrochemical detection of N7-and O 6 -MeGua described by de Groot et al. (1994) was briefly as follows: Per 180 /zl DNA (1-1.5 mg/ml). 100 pmol N7-ethylguanine (N7-EtGua; internal standard) and 20 \A 1 M HC1 were added, followed by incubation at 70°C for 30 mm. The hydrolyzed bases were separated by HPLC on a Partisil 10 SCX column (250 X 4.6 mm, 10-/zm particles; eluens A: 12% methanol; eluens B: 200 min ammonium formate, pH 4.0, 12% methanol; the following gradient was applied: 5% B to 10% B in 10 min and 10% B to 100% B in 5 min: flow rate, 1.5 ml/min). Eluent was collected between ± 8.5 and ±13 min (pool 1) and between ±15 and ±18 min (pool 2). The pools were lyophilized, the residues dissolved in water, and the solutions lyophilized again. Determination of the guanine and adenine peaks in the same elution diagram confirmed the DNA concentration in the samples (deviation from A lm method was less than 10%).
N7-MeGua and N7-EtGua present in pool 1 were determined following separation by HPLC on a Chromspher C-18 column (200 x 3 mm, 5-Tm particles; eluens: 25 min H 3 PO 4 -KOH, pH 6.0, 5% methanol; flow rate, 0.5 ml/min) with electrochemical detection (Antec detector, Leiden, The Netherlands; oxidation potential 1100 mV) (Park et al, 1989) . O 6 -methylguanine (O 6 -MeGua) present in pool 2 was analyzed with nearly the same method (eluens: 25 mM H 3 PO 4 -KOH, pH 6.0, 8% methanol; V o , 1000 mV).
After neutral hydrolysis, the analysis of N7-adducts was performed as follows. Two hundred microliters of DNA was heated for 1 hr at 100°C and cooled to 0°C followed by addition of 20 \i\ 1 M HCI. After 10 min on ice, the DNA precipitate was collected by centrifugation (Eppendorf 5414, 5 min at 12,000 rpm at 4°C). Supernatant (200 fi\) was removed, neutralized with 27 fi\ 1 M K 2 HPO 4 , and analyzed by HPLC with electrochemical detection (HPLC-EC).
RESULTS
Electrochemical Detection of N7-MeGua and Cf-MeGua
Before analysis by HPLC in combination with electrochemical detection of eluted compounds, DNA samples were mixed with a fixed amount of N7-EtGua. This was used later on as an internal standard, in order to correct for losses during the subsequent steps. After HPLC separation two pools of fractions were collected: pool 1 contained N7-MeGua and N7-EtGua and pool 2 contained O 6 -MeGua. The pools were analyzed by HPLC-EC (Fig. 1) . Minor contamination of pool 1 with adenine, which is only partly separated from N7-MeGua by chromatography on the reversed-phase column (cf. Fig. 1 A) , may have some influence on the accuracy of the N7-MeGua determinations, especially at low adduct levels. The recovery of N7-EtGua, and therefore of N7-MeGua, varied between 60 and 90%. The results of these determinations, depicted in Fig. 2 , show a dose-dependent increase of N7-MeGua after exposure of the rats to more than 0.1 mg hydrazine per kilogram, reaching 39 ± 5 N7-MeGua per 10 6 nucleotides after dosage with 10 mg/kg. At lower exposure levels no differences can be observed between the various dosages and the untreated control; a background level of 1.3 ± 0.5 N7-MeGua per 10 6 nucleotides is reached. In salmon sperm DNA, used as a control, N7-MeGua could not be detected (less than 0.36 N7-MeGua per 10 6 nucleotides, see Fig. 1C ). HPLC-EC analysis of DNA hydrolyzed under neutral conditions obtained from rats dosed with 10 mg/kg could not demonstrate the presence of N7-ethyl adducts (less than 0.45 N7-adduct per 10 6 nucleotides). Analysis of neutrally hydrolyzed liver RNA from an untreated rat showed that it contains 180 ± 30 N7-MeGua per 10 6 nucleotides; analysis after acid hydrolysis gave comparable results.
Pool 2 was also analyzed by HPLC-EC on a reversedphase column. No O 6 -MeGua could be detected with this method in DNA samples of rats treated with 7 or 10 mg/ kg, indicating a level of less than 0.55 O 6 -MeGua per 10 6 nucleotides. In a positive control sample-from a rat dosed with 75 mg MNU per kilogram-14 ± 1 O 6 -MeGua per 10 6 nucleotides were present. The level of N7-methylation in this sample was 370 ± 40 N7-MeGua per 10 6 nucleotides.
Immunochemical Detection of N7-MeGua
Before immunochemical analysis, the DNA samples were treated with alkali in order to convert N7-MeGua in the DNA into imidazole ring-open N7-MeGua (the antibody used in this assay recognizes the ring-open derivative but not the parental form). After neutralization, assessment of N7-methylations was performed in a competitive ELISA. A dosedependent increase of N7-methylations was observed in the liver DNA samples of rats exposed to more than 0.1 mg hydrazine per kilogram (Fig. 2) . At 10 mg/kg, 45 ± 14 N7-MeGua were present per 10 6 nucleotides. Dosing with 0-0.1 mg/kg hardly had an effect on the 50% inhibition points, i.e., on the level of N7-MeGua detected, which suggests a background level of 1.1 ±0.2 N7-MeGua per 10 6 nucleotides. This level was also observed when N7-MeGua was removed from DNA by temperature-induced neutral hydrolysis prior to alkali treatment and competitive ELISA. The 50% inhibition point of untreated salmon sperm DNA corre- 
Immunochemical Detection of O 6 -MeGua
The methylation of the Opposition of guanine was also analyzed by use of a highly specific monoclonal antibody against this adduct. After HPLC separation of the 2'-deoxymononucleosides, a competitive RIA was performed on the corresponding fractions to quantify O 6 -MedGuo. From inhibition of tracer-antibody binding, the O 6 -MeGua concentration in liver DNA of untreated controls was calculated to be 1.4 ± 0.5 nmol/mol deoxyguanosine. This corresponds to 0.27 O 6 -MeGua per 10 9 nucleotides. A drastic increase of this value was observed in rats exposed to hydrazine in the range of 0.7 to 10 mg/kg, resulting in 2.6 0 6 -MeGua per 10 9 nucleotides (0.7 mg hydrazine/kg) up to 134 O 6 -MeGua per 10 9 nucleotides (10 mg/kg) (Fig. 3) . No differences in the frequency of guanine O 6 -methylation in liver DNA were observed comparing untreated controls and rats exposed to hydrazine doses of 0.2 mg/kg.
DISCUSSION
Aberrant methylation has been proposed as a mechanism for the mode of action of hydrazine. This compound belongs to a group of chemicals for which there is evidence that the in vivo genotoxic effects become manifest only upon exposure to toxic dose levels. This may imply the existence of a threshold at low doses, below which the methylation would not take place. The experiments described in this paper were carried out to investigate whether a threshold can be detected in the pattern of hydrazine-induced DNA methylations.
The data presented here indicate that treatment of rats with hydrazine induces methylation of liver DNA at dosages below the maximum tolerated dose. With two different methods, immunochemical detection and HPLC separation followed by electrochemical detection, the formation of N7-MeGua has been demonstrated at 16 hr after administration of the hydrazine (Fig. 2) . The results of both assays are very similar. A dose-dependent methylation of the N7 of guanine is observed when rats are dosed with 0.1-10 mg hydrazine per kilogram, reaching 39-45 N7-MeGua per 10 6 nucleotides after exposure to 10 mg/kg. Below 0.1 mg/kg, a background level is observed (1.1-1.3 N7-MeGua per 10 6 nucleotides). 0 6 -MeGua levels were analyzed by a very sensitive radioimmunoassay. This analysis showed a dose-dependent increase above 0.2 mg hydrazine/kg, reaching 134 O 6 -MeGua residues per 10 9 nucleotides at 10 mg/kg, and a background level of 0.27 O 6 -MeGua per 10 9 nucleotides (Fig. 3) .
In the dose range between 0.7 and 10 mg hydrazine/kg, the increase of 0 6 -MeGua levels in DNA (49-fold) was much larger than that for N7-MeGua (12-fold). This is probably due to repair of O 6 -MeGua during the 16-hr posttreatment period, depending on initial adduct levels and depletion of the suicidal repair protein O 6 -alkylguanine-DNA alkyltransferase. Depletion will occur sooner at higher hydrazine doses, thus leading to relatively less repair of O 6 -MeGua (Hall et al, 1990) . N7-MeGua lesions are much more persistent than O 6 -MeGua and no saturation of its repair has been reported.
The background level of N7-MeGua determined immunochemically coincides with the detection limit of the technique. This conclusion is based on the following observations: (1) untreated salmon sperm DNA displays the same background level, whereas the electrochemical method (see below) shows a lower level; and (2) removal of N7-MeGua from DNA by temperature-induced neutral hydrolysis followed by alkali treatment does not result in a decrease of the immunochemical signal.
The background level of N7-MeGua detected electrochemically represents a real background level of adducts in the rat liver DNA samples and not a detection limit, because in untreated salmon sperm DNA lower levels have been determined. This background level might in part be due to contamination of the samples with small amounts of RNA, as eukaryotic RNA contains N7-MeGua in the capped 5'-end of messenger RNAs and in the variable loop of many transfer RNAs (Nevins, 1983; Sprinzl et al., 1989) . If the DNA preparations contained 0.1% RNA, this would result in 0.18 N7-MeGua per 10 6 nucleotides (in liver RNA from an unexposed rat, 180 N7-MeGua per 10 6 nucleotides were determined by HPLC-EC). Because the observed background is higher than this value, the difference (±1.1 N7- 6 -MeGua in liver DNA of rats exposed to hydrazine. O 6 -MeGua in the samples was analyzed by competitive RIA after HPLC separation. DNA from three rats (0 and 0.7 mg/kg) or four rats (0.2 mg/kg) was pooled and analyzed, and DNA from single rats was analyzed (2-10 mg/kg; two rats per dose). Values for 0 6 -MeGua are means of two independent RIA measurements each performed in duplicate.
MeGua per 10
6 nucleotides) would represent the level of N7-MeGua normally present in rat liver DNA. Background levels of N7-MeGua in liver DNA of unexposed rats have been reported previously, though the exact amount is unclear (Park and Ames, 1988a,b) .
Despite intensive research in the past decade, there is still no certainty about the mechanism of hydrazine-induced methylation of DNA in vivo. Administration of [ 14 C-methyl]-methionine or [
14 C]formate resulted in the formation of Relabeled N7-and O 6 -MeGua in liver DNA of hydrazinetreated animals (Quintero-Ruiz et al., 1981; Becker et al., 1981) . This led to the suggestion that the source of the methyl group could be S-adenosylmethionine (SAM). Indeed, nonenzymatic methylation of DNA by SAM in vitro yields formation of N7-MeGua and 0 6 -MeGua in a 12:1 ratio according to one study, but according to another study only N7-MeGua is formed (Rydberg and Lindahl, 1982; Barrows and Magee, 1982) . Furthermore, this suggestion was contradicted by the fact that increase of the hepatic SAM pool following methionine administration did not influence liver DNA methylation in hydrazine-treated animals (Shank, 1983) .
It has also been proposed that hydrazine reacts with endogenous formaldehyde to yield formaldehyde hydrazone (FH) and/or tetraformyltrisazine (TFT), which after metabolic activation methylate DNA (Bosan etai, 1986; Lambert et al., 1986) . Because TFT appears to be formed only at high concentrations of hydrazine and formaldehyde, it may not be important in vivo. FH, however, is formed at low concentrations (Lambert and Shank, 1988) . When exposed to catalase and/or catalase-like enzymes, a mixture of hydrazine and formaldehyde is converted into a methylating agent (Lambert and Shank, 1988) . A possible pathway for this is oxidation of FH by catalase, leading in several steps to diazomethane. This is a well-known methylating agent, formed as the reactive species of methylnitrosourea and many iV-nitrosamines. Indeed, the N7/O 6 -ratio formed in vitro in DNA by FH + catalase is approximately 10, which is comparable to that induced by diazomethane (Lambert and Shank. 1988; Beranek, 1990) . This mechanism seems less important in vivo, as we observed an N7/O 6 -ratio of 300 or more for hydrazine (10 mg/kg) and of 26 for MNU. However, at a much higher hydrazine dose (90 mg/kg) an N7/O 6 -ratio of 13 at 24 hr posttreatment has been described (Beckert et ai, 1981) . The discrepancy with our data may be due to fast repair of O 6 -MeGua until depletion of the repair protein O 6 -alkylguanine-DNA-alkyltransferase occurs, which affects the N7/O 6 -ratio more strongly at lower dosages than at higher dosages (Den Engelse et ai, 1981; Hall et ai, 1990 ). If we correct for this, assuming 3.4 AGT per 10 6 nucleotides in liver (Gerson et at., 1986) , the initial O 6 -MeGua level might have been 3.6 and the N7/O 6 -ratio might have been 12.
Recently, another pathway has been proposed for FHdependent DNA methylation, viz. activation by catalase to methyl free radicals. This activation has indeed been observed in vitro (Gomes and Augusto, 1991) . Organic free radicals play a dominant role, relative to oxygen free radicals in hydrazine-mediated DNA strand scission (Runge-Morris et ai, 1994) . Methyl free radicals are known to induce DNA methylation in vitro, leading to the formation of N7-MeGua and C8-MeGua (ratio AF 3; Augusto et ai, 1990) . The latter adduct is not induced by diazomethane. It is unknown whether methyl free radicals are formed in vivo after administration of hydrazine and lead to the formation of C8-MeGua.
Comparison between the results of the single-dose experiment performed in this study and the data from chronic studies in which hydrazine is administered, e.g., in the drinking water, can only be made in an indirect way. A daily dose of 0.6 mg/kg via the drinking water (10 mg/liter), given during the entire life span of rats, was the maximum tolerated dose and was shown not to be carcinogenic (Steinhoff and Mohr, 1988) . This dose per day is higher than the single oral dose of 0.1 mg/kg, above which hydrazine-induced DNA methylations were detectable. These findings imply that genotoxic effects due to exposure to hydrazine are already manifest at dosages below the maximum tolerated dose and suggest that the methylation is not toxicity related.
The results presented here show that at nontoxic and weakly toxic, but noncarcinogenic, dose levels of hydrazine DNA methylations are detectable in rat liver, both at the N7-and the Opposition of guanine. With decreasing dose, the number of N7-methylations appears to reach a plateau, which reflects the background level of this type of lesion in the rat liver. The induction curve of O 6 -MeGua as a function of the hydrazine dose also shows an apparent threshold below 0.2 mg/kg. Whether these thresholds of methyl-DNA lesions are accompanied by a threshold for carcinogenic activity is still unknown.
The presence of DNA methylation products, e.g., the miscoding 0 6 -MeGua, may give rise to mutations, which may ultimately lead to tumor formation. However, the adduct levels in DNA-especially of O 6 -MeGua-were much lower than observed with carcinogenic doses of methylating compounds like A'-nitrosamines (Belinsky et al, 1990) . Therefore, the sensitivity of the carcinogenesis bioassay would probably not be sufficient to yield a significant response, and the doses would be regarded as noncarcinogenic.
The implication of the present study, with hydrazine inducing genotoxic effects at nontumorigenic and nontoxic dose levels, with respect to chemical carcinogenicity testing, is that testing at the maximum tolerated dose is required to reveal a possible carcinogenic potential, as at lower dose levels the carcinogenesis test may not be sensitive enough.
